According to marketresearch.biz In-Vitro Diagnostics Market Demand and Trend
The in-vitro diagnostics (IVD) market is witnessing continuous growth due to the increasing prevalence of chronic diseases, a growing geriatric population, and a rise in demand for rapid and accurate diagnostic tests. IVD plays a crucial role in disease diagnosis, management, and personalized medicine, driving adoption across healthcare settings. Technological advancements, such as point-of-care testing and molecular diagnostics, are also influencing market expansion.
Market Segmentation
By products and services
- Reagents & kits
- Instruments
- Services
By techniques
- Clinical chemistry
- Basic metabolic panel
- Electrolyte panel
- Liver panel
- Lipid profile
- Renal profile
- Thyroid function panel
- Specialty chemical tests
- Immunochemistry/Immunoassay
- Enzyme-linked immunosorbent assay (ELISA)
- Radioimmunoassays (RIA)
- Rapid tests
- Western blot
- ELISPOT
- Hematology
- Coagulation & hemostasis
- Clinical microbiology
- Molecular diagnostics (MDx)
- Polymerase chain reaction (PCR)
- Isothermal nucleic acid amplification technology (INAAT)
- Microarrays
- Hybridization
- DNA sequencing & next-generation sequencing
- Other MDX techniques
- Other techniques
By application
- Infectious Diseases
- Cancer
- Cardiac Diseases
- Immune System Disorders
- Nephrological Diseases
- Gastrointestinal Diseases
- Other applications
By end-user:
- Hospitals
- Laboratories
- Academic Institutes
- Other end users (Point-Of-Care testing and Patient self-testing)
Top Important players
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories Inc.
- BioMérieux
- Becton
- Dickinson and Company
- Johnson and Johnson
- Qiagen N.V.
- Ortho-Clinical Diagnostics Inc.
- Diasorin S.P.A.
In-Vitro Diagnostics Market size Restraints and Opportunities